Favi, Evaldo
 Distribuzione geografica
Continente #
NA - Nord America 669
EU - Europa 439
AS - Asia 168
AF - Africa 16
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.299
Nazione #
US - Stati Uniti d'America 666
DE - Germania 171
SE - Svezia 83
CN - Cina 70
UA - Ucraina 61
SG - Singapore 52
IE - Irlanda 34
IT - Italia 31
ID - Indonesia 19
CI - Costa d'Avorio 16
FI - Finlandia 16
FR - Francia 14
GB - Regno Unito 14
IN - India 14
IR - Iran 5
RU - Federazione Russa 5
JP - Giappone 4
BR - Brasile 3
CA - Canada 3
BE - Belgio 2
CL - Cile 2
NL - Olanda 2
TR - Turchia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
KR - Corea 1
MN - Mongolia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 1.299
Città #
Chandler 196
Singapore 40
Ashburn 37
San Mateo 35
Dublin 33
Jacksonville 30
New York 29
Wilmington 25
Ann Arbor 23
Dearborn 20
Jakarta 19
Abidjan 16
Boston 13
Redwood City 12
Beijing 11
Fairfield 11
Nanjing 11
Nürnberg 11
Princeton 11
Houston 9
Lawrence 8
Milan 7
Nanchang 7
Augusta 6
Hebei 6
Los Angeles 6
Woodbridge 6
Boardman 5
Guangzhou 5
Moscow 5
Zhengzhou 5
Cattolica 4
Marseille 4
Shenyang 4
Costa Mesa 3
Helsinki 3
Leawood 3
Santa Clara 3
Seattle 3
São Paulo 3
University Park 3
Bremen 2
Brussels 2
Busto Arsizio 2
Cambridge 2
Frankfurt am Main 2
Fremont 2
Groningen 2
Izmir 2
Kish 2
Kunming 2
Lancaster 2
Las Vegas 2
Lomazzo 2
Mountain View 2
Naples 2
Norwalk 2
Paris 2
Phoenix 2
Pune 2
San Francisco 2
Saronno 2
Shanghai 2
Shenzhen 2
Tokyo 2
Toronto 2
Austin 1
Bangalore 1
Carson City 1
Castelnuovo Rangone 1
Changchun 1
Changsha 1
Dallas 1
Essen 1
Esslingen am Neckar 1
Fano 1
Haikou 1
Indiana 1
Jiaxing 1
Jinan 1
Lanzhou 1
Lisbon 1
London 1
Manchester 1
Monmouth Junction 1
Munich 1
Oslo 1
Ottawa 1
Pingdingshan 1
Rome 1
San Jose 1
Simi Valley 1
Tappahannock 1
Tianjin 1
Ulaanbaatar 1
Vancouver 1
Xian 1
Totale 772
Nome #
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 100
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 96
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 92
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 92
Significant improvement in patient survival after renal transplantation in the last decade. 86
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 86
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 85
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 85
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 72
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 68
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 63
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 63
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 58
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 55
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 55
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 46
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 43
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 35
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 31
Totale 1.311
Categoria #
all - tutte 5.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 5 2 22 3 14 6 29 20
2020/2021141 3 16 0 15 22 18 12 3 17 3 30 2
2021/2022148 5 15 1 3 6 2 3 32 10 15 18 38
2022/2023432 49 62 24 91 19 54 24 37 60 4 7 1
2023/2024134 11 45 3 16 3 25 6 1 2 5 8 9
2024/202582 4 13 22 30 13 0 0 0 0 0 0 0
Totale 1.311